NCT06965101View on ClinicalTrials.gov

To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway

NANot yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2028

Conditions
Metastatic Spinal Cord Compression
Interventions
RADIATION

Radiotherapy to the spine in a single appointment

8Gy/ 1# to be delivered to all participants using a single posterior direct field.

Trial Locations (1)

M20 4BX

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors
lead

The Christie NHS Foundation Trust

OTHER

NCT06965101 - To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway | Biotech Hunter | Biotech Hunter